Product Information

DENAVIR 1% CREAM is a brand product labeled by Mylan Pharmaceuticals Inc., priced at $155.9110 per GM under NDC 00378972055. Its NADAC has been published 420 times since Nov 7, 2018.

FDA first approved this application on Sep 24, 1996. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the penciclovir market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

DENAVIR 1% CREAM

penciclovir
$155.9110per GM
High Outlier

Strength

10 mg/g

NDC

00378972055

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

PENCICLOVIR

Approval Type

New Drug (NDA)

FDA Application

NDA020629

FDA Approved

9/24/1996

TE Code

AB

On Market Since

9/24/2018

Pharmacological Classes

DNA Polymerase Inhibitors
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Nucleoside Analog

Price Statistics

The NADAC for DENAVIR 1% CREAM has been published 420 times since Nov 7, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$155.9110 per GM
All-time high$156.2449 (Jun 16, 2021)
All-time low$154.4112 (Jun 17, 2026)
52-week high$155.9110
52-week low$154.4112
Median price$155.7959
Average price$155.6396
Largest weekly change+0.6% (Aug 21, 2019)
Weeks tracked420
Tracking sinceNov 7, 2018

Price History

1W

+0.4%

1M

+0.5%

3M

+0.5%

6M

+0.6%

1Y

+0.7%

3Y

+0.0%

5Y

+0.1%

All

+0.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 64% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DENAVIR 1% CREAM?

The current National Average Drug Acquisition Cost (NADAC) for DENAVIR 1% CREAM, manufactured by Mylan Pharmaceuticals Inc., is $155.9110 per GM (NDC 00378972055), effective Nov 18, 2026.

How has the price of DENAVIR 1% CREAM changed over time?

Over the history we have for it, the NADAC for DENAVIR 1% CREAM has held within roughly two percent of its current level. It has been tracked across 420 weekly CMS publications since Nov 7, 2018.

What are the highest and lowest recorded NADAC prices for DENAVIR 1% CREAM?

Since Nov 7, 2018, the NADAC for DENAVIR 1% CREAM has ranged from a low of $154.4112 (Jun 17, 2026) to a high of $156.2449 (Jun 16, 2021), with a median of $155.7959 per GM.

Are there cheaper alternatives to DENAVIR 1% CREAM?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PENCICLOVIR 1% CREAM, is $55.8633 per GM — about 64% below DENAVIR 1% CREAM.

Who manufactures DENAVIR 1% CREAM?

DENAVIR 1% CREAM (NDC 00378972055) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a brand product.